http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004041773-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46be20e75b3deffea63e3033dbd91554 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C209-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-42 |
| filingDate | 2003-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b34f98fa509c50084d69cf53c5e6081f |
| publicationDate | 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2004041773-B1 |
| titleOfInvention | Process for preparation of polymorphic form of sertraline hydrochloride |
| abstract | The invention discloses a process for preparation of sertraline salts particularly sertraline hydrochloride Form V by dissolving or suspending sertraline mandelate in a solvent, reducing the pH of the solution or the suspension and isolating salt of sertraline. The invention also provides for a pharmaceutical composition comprising said sertraline salt as active ingredient. |
| priorityDate | 2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.